Back
InMed Pharmaceuticals, Inc. 10K Form
Sell
25
INM
InMed Pharmaceuticals, Inc.
Last Price:
$1.20
Seasonality Move:
14.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INM News And Ratings
See the #1 stock for the next 7 days that we like better than INM
INM Financial Statistics
Sales & Book Value
| Annual Sales: | $4.9M |
|---|---|
| Cash Flow: | $-1.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.45 |
| Price / Book: | 0.29 |
Profitability
| EPS (TTM): | -6.90960 |
|---|---|
| Net Income (TTM): | $-8.2M |
| Gross Margin: | $1.2M |
| Return on Equity: | -88.06% |
| Return on Assets: | -71.79% |
InMed Pharmaceuticals, Inc. Earnings Forecast
Key InMed Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 25 years for INM is 23.71%.
-
The Selling, General & Administrative Expenses for INM have been equal to 132.68% of Gross Profit Margin.
-
The Research & Development expenses have been 57.74% of Revenue.
-
The Net Earning history of INM is -165.14% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 15 years.
InMed Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | INM |
| Website: | inmedpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 6.95 |
| Quick Ratio: | 6.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INM Technical Analysis vs Fundamental Analysis
Sell
25
InMed Pharmaceuticals, Inc. (INM)
is a Sell
Is InMed Pharmaceuticals, Inc. a Buy or a Sell?
-
InMed Pharmaceuticals, Inc. stock is rated a SellThe current InMed Pharmaceuticals, Inc. [INM] share price is $1.19. The Score for INM is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.